Press Releases

Shareholders are encouraged to vote before the deadline of 10:00 am (EST) on June 17, 2019 Canopy Growth’s brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage’s growth. Acreage shareholders will benefit from Acreage’s ability to achieve its growth strategy with an anticipated reduced cost of capital based on Canopy Growth affiliation. Canopy Growth shareholders will benefit from accelerated and turnkey access to the U.S. cannabis market upon the closing of the Transaction. Management of both firms believe they will create greater shareholder value together than as…

SMITHS FALLS, ON – Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED, NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines through clinical trials. Demand for cannabinoid-based medicines is emerging around the world. With a highly experienced scientific team and the resources needed to conduct robust clinical trials, Spectrum Therapeutics is pursuing research to introduce products for the therapeutic areas of pain, mood and sleep and to gain access to new markets independent of medical cannabis laws. CLINICAL RESEARCH Spectrum Therapeutics is…

Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed Mirabel, Québec – Les Serres Vert Cannabis Inc. (“Vert Mirabel”), a subsidiary of Canopy Growth Corporation (TSX:WEED, NYSE:CGC) (“Canopy Growth”) and a portfolio company of Canopy Rivers Inc. (TSXV:RIV; OTC:CNPOF) (“Canopy Rivers”) has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand (“Bertrand”). “We are thrilled that the operational…

NEW RESOURCES INFORMED BY THE SENSIBLE CANNABIS EDUCATION TOOLKIT GOAL IS TO HELP PARENTS JUMPSTART CONVERSATIONS WITH YOUTH ABOUT CANNABIS USE SMITHS FALLS & TORONTO, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce the next phase in its partnership with Parent Action on Drugs (“PAD”) and Canadian Students for Sensible Drug Policy (“CSSDP”) which will see PAD launch two new digital tools to help youth along with their parents, adult caregivers, and influencers, on how to make responsible decisions about cannabis use. “Weed Like to Know” Chatbot PAD employed the technical expertise…

Canopy Growth’s brands, technology and know-how is anticipated to provide Acreage with a significant and immediate advantage in an increasingly competitive U.S. market and fuel Acreage’s growth. Acreage shareholders to receive immediate upfront cash consideration, on an as-converted to Subordinate Voting Share basis, of approximately US$2.51 – $2.63 per share upon the initial implementation of the Transaction. On completion of the Transaction, each Acreage share will be converted into 0.5818 of a common share of Canopy Growth, subject to any required adjustments. This represents a premium of approximately 40% over the 30-day volume weighted average trading price of the Subordinate…

London-based firm will be integral part of Canopy Growth’s entry into the natural wellness industry and further strengthens the Company’s international presence SMITHS FALLS, CANADA and LONDON, ENGLAND— Canopy Growth Corporation (TSX: WEED, NYSE: CGC) (the “Company” or “Canopy Growth”) has finalized an all-cash transaction to acquire This Works for a purchase price of £43 million (CDN $73.8 million). Founded in 2004, This Works has cemented itself as a global leader in natural skincare and sleep solutions with a devout customer base spanning 35 countries. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution…

THE COMPANY AND BOARD OF DIRECTORS THANK TIM SAUNDERS FOR CONTRIBUTIONS IN SHAPING CANOPY GROWTH’S CULTURE AND SUCCESS SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce the appointment of Mike Lee to its executive leadership team in the acting role of Chief Financial Officer (CFO), effective June 1, 2019. Mike’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company. Mike brings a wealth of experience from the consumer goods & beverages industry, having worked for companies such as…

SMITHS FALLS, ON—Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. (“PharmHouse”), a 49 per cent-owned joint venture of Canopy Rivers Inc. (TSXV:RIV, OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked…

SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company’s ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth’s medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company (“C3”), a European leader in cannabinoid-based medical therapies. Incorporating these entities into one unified ecosystem will integrate the Company’s medical efforts as one global healthcare enterprise. Spectrum Therapeutics now encompasses the production and distribution of full-spectrum and single cannabinoid…

Founded by top global herbal medicine manufacturer Bionorica SE, C3 is a leader in cannabinoid-based medical therapies used by European physicians to treat patients The acquisition brings together Canopy Growth’s medical business with Europe’s largest cannabinoid-based pharmaceuticals company. C3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in Germany, Austria, Switzerland, and Denmark. Dronabinol was the first cannabinoid product in Germany that could be prescribed by the country’s physicians. In 2018, C3 supplied approximately 19,500 patients in Germany with dronabinol, achieving a YOY increase of 85%. In 2018, C3 achieved sales of approximately €27.1 million (CDN$…

Canopy Growth will transform the (appropriately spotless former vacuum parts) building this summer in Kirkwood, NY for previously announced Hemp Industrial Park SMITHS FALLS, ON & KIRKWOOD, NY — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce a key milestone in establishing its Hemp Industrial Park in the Southern Tier region of New York State. The Company has secured a 308,000 sq. ft. facility on a 48-acre property in Kirkwood, NY. Design activities will commence immediately with construction commencing this summer. The vision for the property is to build the infrastructure necessary to support…

SMITHS FALLS, ON and TORONTO, ON – Spectrum Cannabis, the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce a partnership with the Arthritis Society to raise awareness and educate people about living with arthritis, including the potential of medical cannabis as a treatment for arthritis symptoms and the importance of seeking guidance from health care practitioners. The Arthritis Society is a leading charitable funder of arthritis research whose vision is to live in a world where people are free from the devastating effects of arthritis. The partnership will engage Canadians across the country in a series…